The other three patients with coexisting anti‐CRMP1 and anti‐CRMP2 Abs were diagnosed with autoimmune encephalitis (anti‐GFAP antibody), possible Wernicke encephalopathy, and subacute combined degeneration, respectively. Here, DPYSL2 is linked to Subacute Combined Degeneration.